$ERNA +22% Premarket 🚀 🔹 Huge move after Ernexa announced breakthrough preclinical data for ERNA-101 in ovarian cancer models 📈 🔹 ERNA-101 + PD-1 blockade a

$ERNA +22% Premarket 🚀 🔹 Huge move after Ernexa announced breakthrough preclinical data for ERNA-101 in ovarian cancer models 📈 🔹 ERNA-101 + PD-1 blockade achieved 100% survival and complete tumor elimination 🔥 🔹 Treatment showed complete tumor clearance with long-term durable survival in prec…